China Wants to Patent Gilead’s Experimental Coronavirus Drug – Bloomberg
Business News
- China Wants to Patent Gilead’s Experimental Coronavirus Drug Bloomberg
- An experimental antiviral medication might help fight the new coronavirus The Verge
- Gilead Won’t Profit Off Coronavirus, Analyst Says. Buy the Stock Anyway. Barron’s
- China lab seeks patent on use of Gilead’s coronavirus treatment Reuters
- China is trying to patent an experimental anti-coronavirus drug Aljazeera.com
- View full coverage on Google News
Source: Business News